Previous 10 | Next 10 |
InMode Ltd. (INMD) Q2 2021 Earnings Conference Call July 28, 2021, 8:30 AM ET Company Participants Miri Segal - Investor Relations Moshe Mizrahy - Chairman of Board and Chief Executive Officer Shakil Lakhani - President, North America Yair Malca - Chief Financial Officer Spero Theodorou - Chi...
InMode Reports Record Second Quarter 2021 Financial Results: Quarterly Revenues of $87.3 Million Represent 184% Year Over Year Growth PR Newswire YOKNEAM, Israel, July 28, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode") , a leading global provider of i...
Artystarty/iStock via Getty Images Thanks to the prospects of earning a spot in the S&P 500 Index, Moderna (MRNA) jumped ~23.0% this week to breeze past $100B market capitalization. The frontrunner in COVID-19 vaccine development has taken less than three yea...
The CPI-W increased 6.1% year-over-year in June. Healthcare is historically a strong performer later in the business cycle. The healthcare sector is improving in our large cap sector ranking. Top scoring healthcare stocks worth adding to your watch list. For further deta...
InMode Ltd. (NASDAQ:INMD) traded at a new 52-week high today of $112.19. So far today approximately 188,000 shares have been exchanged, as compared to an average 30-day volume of 672,000 shares. InMode Ltd. (NASDAQ:INMD) is currently priced 32.0% above its average consensus analyst price...
naphtalina/iStock via Getty Images Elon Musk loves a platform. Does a witness box count? Apparently, yes. Tesla (TSLA) shares got a boost on Monday as its founder testified in a shareholder lawsuit related to the firm's SolarCity acquisition. Other players in the electric vehicle space got a ...
Medical technology specialist InMode (NASDAQ: INMD) was a very in-fashion stock Monday. The company's shares zoomed 12.5% higher, on the back of very encouraging preliminary results and raised guidance. According to its preliminary calculations, InMode will post record revenue i...
InMode ([[INMD]] +12.3%) trades higher after forecasts a jump in second-quarter earnings and raised its guidance for revenue for the full year.The company sees Q2 revenue of $86.5M to $87.0M vs. $65.98M consensus. Adjusted earnings per diluted share of $1.00 to...
InMode Expects Record Second Quarter 2021 Revenue Between $86.5M-$87.0M, Increasing Full Year 2021 Revenue Guidance to $305-$315M Conference call to be held on July 28 at 8:30 a.m. Eastern Time PR Newswire YOKNEAM, Israel, July 12, 2021 /PRNewswire/ -- InMode L...
Beauty Health is poised for years of growth in the growing global beauty health market. The company is building a platform to add other beauty products and treatments to the global platform and distribution system. Goldman Sachs forecast procedures to triple by 2024 boosting consu...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...